In addition to leading his own research group, Cunningham serves as the PI of the Omics Nanotechnology for Cancer Precision Medicine (ONC-PM) Theme at the Carl R. Woese Institute for Genomic Biology (IGB), where he leads a team for the development of liquid biopsy approaches to cancer diagnostics in collaboration with clinicians at Mayo Clinic.